Thus, it has been suggested that, with similarities to the INS situation for T1D, a gene variant that regulates (mRNA or protein) expression quantitatively in the thymus, can lead to the disease development through inadequate recognition of ‘autoreactive’ T cells and breakdown of negative T cell selection. The gene discussed is INS; the disease is type 1 diabetes mellitus.